Vivex
-
Hospitals
Vivex Biomedical, Inc. Receives Level II HCPCS Q-Code for Cygnus™, a Human Amniotic Tissue Allograft
ATLANTA Dec. 20, 2016 /PRNewswire Vivex Biomedical, Inc. (Vivex) is a biomaterials developer focused on creating treatment options and creative…
Read More » -
Biologics
Novastep Enters into Agreement with Vivex Biomedical to Launch bioSTART® Platform
Orangeburg, NY, May 16, 2016 (GLOBE NEWSWIRE) — Novastep, Inc., and its affiliates (“Novastep” or the “Company”), a global medical…
Read More » -
Biologics
Vivex Biomedical, Inc. and Arthrex, Inc. Enter into Long Term Agreement
MARIETTA, Ga., March 31, 2016 /PRNewswire/ — Vivex Biomedical, Inc. and Arthrex Inc. have signed a new long-term agreement that strengthens…
Read More » -
Financial
Xtant Medical Announces Distribution Agreement with Vivex Biomedical Bringing OsteoVive™, a Cellular Allograft, to Market
BELGRADE, Mont., March 24, 2016 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE:XTNT), a leader in the development of regenerative…
Read More »